普门科技(688389) - 2025 Q4 - 年度业绩

Financial Performance - In 2025, the total operating revenue was RMB 103,783.10 million, a decrease of 9.60% compared to the previous year[3] - The net profit attributable to the parent company was RMB 18,609.47 million, down 46.12% year-on-year[3] - The net profit attributable to the parent company after deducting non-recurring gains and losses was RMB 16,643.18 million, a decrease of 49.28% compared to the previous year[3] - The basic earnings per share were RMB 0.43, reflecting a decline of 46.91% year-on-year[3] Assets and Equity - Total assets at the end of the reporting period were RMB 279,089.18 million, a decrease of 3.58% from the beginning of the period[5] - The equity attributable to the parent company increased by 3.25% to RMB 211,765.19 million compared to the beginning of the period[5] Operational Challenges - The decline in operating performance was primarily due to price reductions in some products influenced by domestic medical insurance payment reforms[5] Strategic Focus - The company maintained stable growth in international marketing, focusing on regional coverage and localized services[5] - The company continued to invest in research and development and marketing to enhance its competitive edge in the market[5] Financial Data Disclaimer - Investors are advised to note that the financial data is preliminary and subject to audit, with final figures to be disclosed in the annual report[7]